The research initiative is part of a broader focus on wearables at the Department of Health and Human Services.
Glucotrack, Inc. (Nasdaq: GCTK) is focused on the design, development, and commercialization of novel technologies for people with diabetes. The Company is currently developing a long-term implantable ...
US-based Sequel Med Tech has introduced its Tidepool-powered twiist automated insulin delivery (AID) system across the country. Following clearance by the US Food and Drug Administration (FDA) in 2024 ...
Discover what happens to your blood sugar when you eat Greek yogurt with berries. Learn how protein, fiber, portion size, and fat content affect post-meal glucose and how to make this combo work for ...
The FDA issued a warning letter to Novo Nordisk, the Danish drugmaker behind the diabetes and weight-loss medications Ozempic and Wegovy, over unreported potential side effects.
A large study found that people taking GLP-1 drugs like Ozempic for diabetes were less likely to be diagnosed with substance use disorder.